Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -31.73 | -17.78 |
PEG Ratio (TTM) | -0.01 | -5.55 |
P/S Ratio (TTM) | 8.88 | 39.43 |
P/B Ratio (TTM) | 1.74 | 5.80 |
P/FCF Ratio (TTM) | 296.42 | -146.47 |
Price to 5YR AVG Earnings Ratio | N/A | -34.01 |
Price to 5YR AVG FCF Ratio | N/A | -1.00 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.47% | 288.99% |
ROE (TTM) | -10.98% | -4,244.29% |
Net Profit Margin (TTM) | -27.97% | -1,050.76% |
ROIC 5YR AVG | N/A | -15.85% |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 873.25% | N/A | N/A |
Revenue | 506.35% | N/A | N/A |
Net Income | -149.70% | N/A | N/A |
Cash Flow | -19.19% | N/A | N/A |
Health (25%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.05 | 4.94 |
Quick Ratio (TTM) | 4.05 | 4.92 |
D/E Ratio (TTM) | N/A | 1.30 |
Interest Coverage (TTM) | -4.53 | -11.46 |
Piotroski F-Score | 2 | 3 |
Altman Z-Score | N/A | 21.03 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 892.04% |